Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma Completed Phase 2 Trials for Buparlisib (DB11666)

IndicationStatusPhase
DBCOND0059568 (Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01693614Safety and Efficacy of BKM120 in Relapsed and Refractory NHLTreatment